1-3 April 2009, Luxembourg.
Register now to benefit from the early bird fees which give you up to 25% discount on the regular registration fees. Registration will give you access to all conference sessions and workshops, expo area, receptions and unprecedented networking and learning opportunities.
The Commission has recently adopted a Communication and proposal for a Council Recommendation with specific actions that Member States can take, either individually, collectively or with the Commission, to improve the safety of patients. Each year, in the EU, between 8% and 12% of patients admitted to hospitals suffer harm from the healthcare they receive, including from healthcare associated infections. Much of that harm is preventable.
21-23 June 2009, Algarve, Portugal.
The use of ICTs (Information and Communication Technologies) in Healthcare Services is the main mechanism to improve efficiency and effectiveness. This conference aims to draw together information systems, practitioners and management experts from all quadrants involved in developing computer technology to improve healthcare quality.
During the 12th Annual Scientific Sessions (January 29 to February 1, 2009) of the Society for Cardiovascular Magnetic Resonance (SCMR), the world's major international society for cardiovascular imaging, the role of perfusion imaging in clinical decision making will be refined.
GP surgeries in Southwark Primary Care Trust (PCT) have been using iPLATO's text messaging solution to invite patients for their MMR jab and to alert parents of the recent measles outbreaks in local schools within the Borough.
IBA Health Group Limited (ASX: IBA), Australia's largest listed health information technology company, announced that its iSOFT European business has signed contracts with two major hospital groups in the Netherlands totalling 8.8 million ($17.6 million).
ICT for Health (eHealth) is looking for experts related to four objectives addressed by the call 4 (& 6 to be launched end 2009) for proposals (1 - Personal Health Systems; 2 - Patient Safety; 3 - Virtual Physiological Human; 4 - International Cooperation in VPH).
Royal Philips Electronics today announced that it is leading a major new European project to develop drug delivery technologies that could significantly impact the treatment of cancer and cardiovascular disease. By allowing drugs to be delivered to disease sites via the patient's bloodstream and then activated by focused ultrasound pulses, the SonoDrugs project aims to maximize the therapeutic efficiency and minimize the side effects of drug treatments for cancer and cardiovascular disease.
Royal Philips Electronics (NYSE: PHG, AEX: PHI) has reported Q4 sales of EUR 7.6 billion. Healthcare showed strong Q4 sales growth of 9% and improved earnings; lower sales at Consumer Lifestyle and parts of Lighting reflect the challenging retail and automotive markets.
The Financing eHealth study was commissioned by DG INFSO and Media's ICT for Health Unit. The aim is to assess different financing opportunities against the financing needs of eHealth investment. The overriding goal of the study, and of this final report, is to assist Member States and the European Commission (EC) in their efforts to meet the eHealth Action Plan objective of "supporting and boosting investment in eHealth".